General Terms and Conditions


  1. Introduction. The following terms and conditions (the “Terms and Conditions”) are incorporated by reference into the Master Software License and Services Agreement (the “Agreement”) between you (“Client”) and Transaction Data Systems, Inc., and/or its subsidiaries and affiliates (“TDS”). Capitalized terms not defined herein shall have the meaning ascribed to such terms in the Agreement. For the sake of clarity, the term “Agreement” shall include these Terms and Conditions.
  2. Software.
    1. The Software includes the following: (i) object code in machine readable form; (ii) required licenses to any third-party software embedded in the Software; and (iii) all documentation and specifications for the Software.

    2. Client will not: (a) decompile, disassemble, or otherwise reverse engineer the Software; (b) attempt to derive the source code form of the Software; (c) intentionally remove or materially alter any trademark, copyright, product identification or other proprietary notices contained in the Software; or (d) create a derivative work of any part of the Software.

    3. Client may not sub-license, assign, or transfer the License or the Software, or any part thereof, except as expressly provided in this Agreement or with the written consent of TDS. Any attempt otherwise to sub- license, assign or transfer any of the rights, duties or obligations hereunder is void. If Client transfers possession of any copy, modification, or merged portion of the Software to another party, Client’s license hereunder is automatically terminated.

    4. Client is required to subscribe to Support Services in order to maintain the License and to use the Software. The License shall automatically terminate, with no further action by TDS, in the event the Support Services are terminated (including termination by TDS for Client’s failure to timely pay for the Support Services).

  3. Hardware.
    1. New Hardware may be returned for a refund or replacement, provided that Client returns the Hardware to TDS forty-five (45) days of the original shipment date. All items returned must be in the original packaging and in “like new” condition, with all components and accessories that were shipped with the original purchase. No refunds or exchanges will be permitted after the forty-five (45) day window has expired.

    2. Any Hardware that is returned must be sent back to the TDS location from which it was shipped.

    3. Unless the Hardware is defective, Client shall pay TDS a 20% restocking fee for any items sent back to TDS for a refund or replacement (based on the original sales price of the returned items).

    4.  The following Hardware related fees are not refundable at any time: all shipping and handling charges, equipment set-up charges, and testing and software installation charges.

    5. TDS shall, to the extent permissible, pass through to Client all available original equipment manufacturer warranties on the Hardware.

    6. Client is responsible for maintaining industry-standard security and compliance features and controls on the Hardware and Client’s IT network. Additionally, Client is responsible for installing all necessary patches and updates for any software installed on the Hardware, including, without limitation, the operating system. TDS assumes no responsibility nor liability for any security-related issues, compliance-related issues, patch maintenance, or similar issues related to the Hardware or Client’s IT network. In no event shall TDS have any obligation or liability to Client for any direct, indirect, incidental, special, exemplary or consequential damages (including, without limitation, any loss of data, revenue or profits or business interruption) or other pecuniary loss arising out of Client's failure to meet its responsibilities in this subsection.

  4. Support Services. 
    1. Updates to Software released for general use and covered under this Agreement (the “Updates”) will be provided to the Client at no additional charge during the Term of this Agreement. Client agrees to install all such provided Updates for use within five (5) business days of receipt. TDS agrees that it will support its most current Licensed Software releases and, if applicable, the immediately preceding release. TDS does not guarantee that it can or will support any older releases of its Licensed Software and reserves the right to discontinue all forms of support for discontinued products and/or older versions of Licensed Software.

    2. The Support Services cover the Software licensed under the Agreement, for use on a system that meets the minimum equipment configuration for the licensed Software, as communicated to Client by TDS (the “Minimum Equipment Configuration”), and as updated with the Updates and any other improvements or modifications furnished to Client under this Agreement. In the event that Client installs the Software or any updated version of the Software on a system that does not meet the Minimum Equipment Configuration for such Software, Client agrees that TDS shall not have any responsibility for the performance of the Software on Client’s system.

    3. Support Services do not cover support for software created by third parties nor do they cover equipment and/or peripheral devices attached to the computer or terminals operating the Software. Calls for support where the problem is determined to be a direct or indirect result or consequence of the Software being incorrectly installed, where such installation was not done directly by TDS personnel or not in accordance with TDS installation instructions, may result in non-covered support charges to Client at TDS’ then-current hourly support rates.

    4. TDS may change the terms and conditions associated with the Support Services upon thirty (30) days written notice to Client; such written notice may be provided in generally distributed TDS literature such as a newsletter or as an amendment to the Agreement of these Terms and Conditions. 

    5. Client agrees to install and maintain for the duration of this Agreement a high‐speed internet connection acceptable to TDS. Client agrees that the internet connection will be reserved for use by the Software.

  5. Confidential Information. 
    1. “Confidential Information” means any and all non-public technical and non-technical information provided by either party to the other, including but not limited to ideas, sketches, techniques, drawings, works of authorship, models, inventions, know-how, processes, apparatuses, equipment, algorithms, software programs, software source documents, and formulae related to the current, future and proposed products and services of each of the parties, and including, without limitation, their respective information concerning research, experimental work, development, design details and specifications, engineering, financial information, procurement requirements, purchasing, manufacturing, customer lists, investors, employees, business and contractual relationships, business forecasts, sales, merchandising, marketing plans and information the disclosing party provides regarding third parties. The Parties expressly acknowledge and agree that the transactions contemplated by the Agreement and the terms, conditions, and negotiations concerning the same, constitute Confidential Information.

    2. Each party agrees: (i) not to use any Confidential Information of the other party for any purpose except in the performance of its obligations under this Agreement or as otherwise expressly permitted hereunder; (ii) to disclose such Confidential Information only to employees (or third party subcontractors permitted under this Agreement) who have a need to know such Confidential Information for purposes of this Agreement and who are under a duty of confidentiality no less restrictive than that set forth herein; (iii) to protect such Confidential Information from unauthorized use, access or disclosure in the same manner that it protects its own similar Confidential Information, but in no event with less care than a reasonably prudent business would exercise; and (iv) to promptly notify the other party of any actual or potential unauthorized access to or use of Confidential Information.

    3. All Confidential Information shall remain the sole property of the disclosing party, and the receiving party shall have no interest in or rights with respect thereto except as expressly set forth in this Agreement.

    4. The foregoing restrictions on disclosure shall not apply with respect to any information which: (i) was or becomes generally known or publicly available through no act or failure to act on the part of the receiving party; (ii) is known by the receiving party without restrictions on disclosure at the time of receiving such information as evidenced by its records; (iii) is rightfully furnished to the receiving party without restrictions on disclosure by a third party without a breach of such third party's obligations of confidentiality; or (iv) is required by law to be disclosed by the receiving party, provided that the receiving party gives the disclosing party prompt written notice of such requirement prior to such disclosure.

    5. This subsection will survive any termination of the Agreement for a period of three (3) years. Notwithstanding the foregoing, with respect to trade secrets, the obligations of this subsection shall remain in effect for as long as such information shall remain a trade secret under applicable law.
  6. Intellectual Property Rights. All title and rights of ownership in the Software, including, without limitation, patents, trademarks, copyrights, service marks, trade names, trade secrets and all other intellectual property rights, belong to, and remain with, TDS. No such rights are transferred to Client under the Agreement, except for the License on the terms and conditions set forth herein.

  7. Backup Services. If Client elects to utilize the TDS Remote Backup Service or other similar data backup service offered by TDS (the “Backup Service”), the following additional terms shall apply with respect to the Backup Service:
    1. The Backup Service, including transmission, storage, viewing and retrieval of data and files is subject to a variety of conditions that make such transmission, storage, viewing and retrieval potentially unreliable, and Client acknowledges that the quality and accuracy of Client's data backup services is dependent on the accuracy, quality, and reliability of Client's data. Accordingly, Client's use of the Backup Service is at Client’s sole risk. The Backup Service is provided to Client on an "as is" basis. TDS disclaims all warranties and conditions, express or implied, arising by law or otherwise, with respect to the Backup Service (including, without limitation, any implied warranties of merchantability, fitness for a particular purposes and non-infringement). TDS makes no representation or warranty that: (a) the Backup Service will meet Client's needs; (b) the Backup Service will be timely, error-free, uninterrupted, or virus-free; (c) Client's data and files will not be lost or damaged; or (d) the data on Client's desktop or server will not be lost or damaged. Client acknowledges that any material or data retrieved through the use of the Backup Service is done at Client's choice and risk and that Client will be solely responsible for any damage to its computer system or loss of data that results from the retrieval of such material or data.

    2. In no event shall TDS have any obligation or liability to Client for the cost or procurement of substitute services or data or for any direct, indirect, incidental, special, exemplary or consequential damages (including, without limitation, any loss of data, revenue or profits or business interruption) or other pecuniary loss arising out of Client's use of the Backup Service or Client's loss of data or files stored therein.
  8. Fees. Unless otherwise stated in the Agreement, or an exhibit or schedule thereto: (a) fees for Support Services are payable in advance of the applicable support period; (b) fees for any Hardware are due at the time Client orders such Hardware and must be paid prior to TDS shipping such Hardware to Client; and (c) fees for all Software and Other Services are due upon receipt of such Software or Other Services. All invoices shall be in U.S. dollars. TDS reserves the right to increase the fees for the Software, Hardware, Switching and any Other Services at any time. No such change in fees shall be effective for Client prior to the end of a pre-paid coverage period and shall not be retroactive.

  9. Invoice Dispute. Client may only withhold payment on any invoiced amounts reasonably disputed in good faith under this Agreement. In the event of a disputed invoice, Client shall: (i) provide TDS notice of any disputed amounts, including a reasonable explanation to support the withholding of any disputed amounts; and (ii) timely pay all undisputed amounts on the invoice. Any dispute to an invoice must be brought to the attention of TDS within thirty (30) days of the date of such invoice, otherwise such invoice will be deemed accepted by Client.

  10. Suspension of Services. In the event that Client fails to timely pay an undisputed invoice, TDS may suspend Services and access to the Software until Client has timely paid all such undisputed invoices.

  11. Data Rights for Pharmacy Programs. As part of the Services offered to Client, TDS may provide certain pharmacy programs to Client and its patients, including, without limitation, programs related to patient safety and education, prescription adherence, prescription refills, medication therapy management, clinical trials, medication history, electronic payments, drug rebates, drug coupon and other patient assistance, and statistical aggregation (the “Pharmacy Programs”). TDS may use Client data, including protected health information when necessary and in accordance with the Business Associate Agreement, to provide the Pharmacy Programs to Client. TDS may also provide such data to business and sub-business associates of TDS to perform services necessary for Patient Programs. Client may opt-out of Pharmacy Programs at any time by providing at least thirty (30) days written notice to TDS of its desire to not participate in such Pharmacy Programs.

    In addition, Enhanced Medication Services, LLC (“EMS”), a subsidiary of TDS, contracts with a variety of industry entities to deliver patient centered programs designed to drive adherence, STAR ratings, improved health outcomes, collaborative care and outstanding community pharmacy performance (the “EMS Programs”). EMS may perform patient outreach to Client’s patients to drive successful patient adherence, education and outcomes related to a variety of Medication Therapy Management functions. EMS Programs sponsored by health insurance companies may require TDS to provide patient information related to the health insurance company’s beneficiaries to the health insurance company on behalf of Client for payment activities or health care operations. TDS may also provide patient information to business and sub-business associates of Client to perform data aggregation services necessary for EMS Programs. Client may opt-out of EMS Programs at any time by providing written notice to TDS of its desire to not participate in such EMS Programs.

  12. De-Identified Data. TDS may use protected health information to create de-identified information (“De-Identified Information”) in accordance with the applicable provisions of 45 C.F.R. § 164.514, and may use and disclose such De-Identified Information: (1) for the purposes described in the Agreement; and (2) to fulfill any legal responsibilities of Client and/or TDS. TDS may also use and disclose such De-Identified Information for any purpose and in any manner consistent with applicable law and may disclose such De-Identified Information to a third party for such third party’s own use; provided, however, that: (1) TDS will not re-identify De-Identified Information and (2) TDS will take reasonable steps to ensure that its workforce, subcontractors and third parties that receive De-Identified Information do not re-identify De-Identified Information.

  13. Diagnostics. Hardware and Software provided by TDS may report various diagnostic data to TDS. Diagnostic data is used only to keep the Hardware and/or Software and up-to-date, detect, diagnose, and fix problems, and also make product improvements. This data does not include any protected health information (“PHI”), any other personally identifiable information, or any information unrelated to TDS Hardware and/or Software.

  14. Switching. If Client elects to use the Software to electronically transmit claims to a third-party (e.g., RelayHealth, Change Healthcare, etc.) for payment from payers (each, a “Switch”), the following additional terms and conditions apply:
    1.  Data Rights. Client grants TDS the right to use and transmit Client data to Client’s selected Switch on Client’s behalf.

    2.  Payment. Client agrees to pay TDS a per claim fee for each claim transmitted to the Switch, at the rate set forth in the Agreement or at TDS’s current rates.

    3. RelayHealth Terms and Conditions. If Client elects to use RelayHealth as its Switch, the following terms and conditions shall apply:
      1. Electronic Prescription Services Terms:
        a. Client shall not use any means, program, or device, or permit any other person to use any means, program, or device, including, but not limited to, advertising, instant messaging, and pop up ads, to influence or attempt to influence, through economic incentives or otherwise, the prescribing decision, as defined below, of a prescriber at the point of care, as defined below, if (i) such means, program, or device is triggered by, initiated by, or is in specific response to, the input, selection, and/or act of a prescriber or his/her agent prescribing a pharmaceutical or selecting a pharmacy for a patient and (ii) that prescription will be delivered via the Electronic Prescription Services Network. "Prescribing decision" means a prescriber's decision to prescribe a certain pharmaceutical or direct the patient to a certain pharmacy. Point of care shall mean the time that a prescriber or his/her agent is in the act of prescribing a pharmaceutical for a patient.

        b. Client shall not: (i) use the Surescripts Network in any manner which would allow the general public access thereto; or (ii) allow any use of the Surescripts Network by entities other than Client. Client shall not access the Surescripts Network outside of the jurisdiction of the United States.

        ii. Patient Assistance Rx:
        a. Client shall communicate the Program Message to the patient.
        b. Client shall use commercially reasonable means in order to ensure the complete Program Message may both be seen by the pharmacy and printed for delivery to the patient.
        c. Client authorizes TDS to allow RelayHealth to access and use historical and prospective prescriptions claims data processed over the RelayHealth Intelligent Network by RelayHealth on behalf of Client.
  15. RelayHealth Commercial E1 Service Terms and Conditions. If Client’s use of the Software utilizes the RelayHealth RealEligibility Commercial E1 Service (the “Commercial E1 Service”), the following additional terms and conditions shall apply:
    1. Definitions. For purposes of these additional flow down terms, the following words and terms will have the meanings set forth below. “Client” means a customer of TDS that has entered into a written agreement pursuant to which TDS provides or makes available to the customer the Commercial E1 Service. “Applicable Law” means any and all federal, state and local laws and regulations that apply to TDS, Client or End Users. “Pharmacy Benefit Manager Data Source” means a pharmacy benefit manager (“PBM”), health benefit payor or administrator, or other similar entity which has entered into a written agreement with Surescripts to allow access through the Surescripts Network to information for the Commercial E1 Service. “End User” means an individual that is employed by, an active member of the medical staff of, workforce of (as defined in 45 C.F.R. § 160.103) or otherwise performing healthcare services as an authorized representative of Client. “Surescripts Data” means any data or information provided to TDS, its Clients and End Users by or through RelayHealth by Surescripts as part of the Commercial E1 Service, including statistics collected by Surescripts regarding transactions processed by the Surescripts Network, test data, test cases, configuration information, and problem description and resolution information; provided, however, that is does not include any data sent by TDS, its Clients or End Users to Surescripts through RelayHealth.

    2. Message Transmission and Content. Client shall comply with Applicable Law. Client shall ensure (a) that each end user of Client authorized to use the Commercial E1 Service meets the definition of End User set forth above; and (b) that each End User is identity proofed in accordance with industry standards to Surescripts’ reasonable satisfaction, pursuant to standards that Surescripts may issue from time to time. Client shall further ensure that each End User is authenticated in accordance with procedures compliant with a national industry standard recognized by Surescripts in its reasonable discretion.

    3. Firewall. Client shall not use the Surescripts Data provided by Pharmacy Benefit Manager Data Sources to promote or encourage TDS or its clients maintaining pharmacy benefit manager services or to augment TDS’s or Client’s own eligibility or medication history records. In the event that Client has pharmacy benefit manager operations, Client shall maintain all Surescripts Data provided by Pharmacy Benefit Manager Data Sources separate or “walled off” from the data from its other pharmacy benefit manager operations, if any.

    4. Patient Consent and Authorizations. Client and Client’s End Users shall comply with any privacy and patient consent policies of Surescripts related to the delivery of Private Information and/or PHI as may be published by Surescripts from time to time and are provided to RelayHealth. Client and its End Users acknowledge that Pharmacy Benefit Manager Data Sources may impose additional privacy and patient consent policies on the delivery of Private Information and/or PHI through the Surescripts Network. Client shall use commercially reasonable efforts to implement any such policies within ninety (90) days following TDS’s receipt of such policies from RelayHealth. In the event that TDS or Client do not implement such policies within ninety (90) days of receipt of such policies from RelayHealth (which shall be no more than thirty (30) days after RelayHealth’s receipt of such policies from Surescripts), then Surescripts shall immediately suspend the Commercial E1 Service responses for such applicable Pharmacy Benefit Manager Data Source.

    5. Use of Data. Client and End Users shall not attempt to capture, open, examine, modify, add commercial or other messages to, repackage, distribute, license, sell or make any commercial use of any data or information provided by any Pharmacy Benefit Manager Data Source by or through the Surescripts Network other than as specifically permitted under the Commercial E1 Exhibit. Client and End Users shall engage in no act or omission which would alter the content of, interfere with, modify, or delay (i) the transmission of any data or information provided by the Pharmacy Benefit Manager Data Sources which is communicated through the Surescripts Network, or (ii) the incoming or outgoing transmission or receipt of any message sent through the Surescripts Network. Surescripts may share Client’s data with other Pharmacy Benefit Manager Data Sources to the extent necessary to fulfill the terms and conditions of the Commercial E1 Exhibit. Nothing in these additional flow down terms or the Commercial E1 Exhibit is intended to restrict use of data or information provided by Pharmacy Benefit Manager Data Sources and obtained or sent through the Surescripts Network once such data or information has become a part of a patient's permanent record.

    6. Limitations of the Surescripts Network. Surescripts uses available technology to match patient identities in order to provide the Commercial E1 Service. Because patient information is maintained in multiple places, not all of which are accessible to Surescripts, and because not all patient information is kept in a standard fashion or is regularly updated, it is possible that false matches may occur or that there may be errors or omissions in the information provided by Surescripts from Pharmacy Benefit Manager Data Sources. Surescripts is not a health plan, health care provider, or prescriber. Surescripts does not and cannot independently verify or review the information transmitted through the Surescripts Network for accuracy or completeness. Neither Surescripts nor any Pharmacy Benefit Manager Data Source provides any representations or warranties with respect to the accuracy or completeness of such information. Pursuant to the foregoing, Client and End Users acknowledge that the Surescripts Data provided by Surescripts from Pharmacy Benefit Manager Data Sources may not be complete or accurate, and hereby releases and holds harmless, RelayHealth, Surescripts and the Pharmacy Benefit Manager Data Sources from any liability, cause of action, or claim related to the completeness or lack thereof of such Surescripts Data.

    7. Indemnification. Client shall indemnify and save harmless TDS from and against any and all loss, damage or expense (or claims of damage or liability) asserted against TDS by third parties arising out of any breach by Client or Client’s End Users of any of the Flow Downs Terms. For the avoidance of doubt, the indemnification obligations outlined in the preceding sentence shall not be subject to any limitation of liability otherwise provided for.

    8. Termination. RelayHealth may terminate the Commercial E1 Service immediately in the event that Surescripts is no longer performing the Commercial E1 Services or the terms of the agreement between RelayHealth and Surescripts pursuant to which RelayHealth may resell the Commercial E1 Services are no longer in force or effect.

  16. FairCom Terms and Conditions. If Client’s use of the Software utilizes the FairCom database software (the “FairCom Technology”), the following additional terms and conditions shall apply:
    1. Deployment. Each copy of FairCom Technology deployed will be authorized for use in one (1) single instance, either on a physical machine or in a virtual machine.

    2. Export Restrictions. Access to and deployment of FairCom Technology is granted with the specific understanding and requirement that responsibility for ensuring full compliance with all applicable U.S. and foreign export laws and regulations is being undertaken by Client. This includes an obligation to ensure that any individual receiving access who is not a U.S. citizen or permanent U.S. resident is permitted access under applicable U.S. and foreign export laws and regulations. In the event Client is uncertain whether Client may lawfully obtain access to the FairCom Technology or Deploy any file created with the FairCom Technology, Client acknowledges its obligation to consult with legal counsel to determine whether access is lawful. Client understands and acknowledges its obligations to make a prompt report to FairCom and the appropriate authorities regarding any access to or use of the FairCom Technology or any file created with the FairCom Technology that may be in violation of applicable U.S. or foreign export laws or regulations. Client will hold FairCom and TDS harmless for any breach by Client of any U.S. or export laws and regulations.

    3. Warranty. FairCom Technology is licensed “as is” and FairCom disclaims any and all warranties, whether express or implied, including, without limitation, any implied warranties of merchantability or fitness for a particular purpose to all persons or users.

    4. Liability. Client unconditionally, irrevocably and completely releases FairCom from any and all liability, damages or claims.

    5. Limited Use. FairCom Technology is authorized for use only with the Software. Renting, leasing or sharing of FairCom Technology is prohibited. Redistribution of FairCom Technology in any form or for any purpose is prohibited.

    6. Notification. Use of FairCom Technology is subject to a separate license agreement between TDS and FairCom, including all the terms, conditions, limitations, restrictions and disclaimers therein; provided, however, that Client’s acceptance of these terms and conditions does not make Client a third-party beneficiary thereof and cannot enforce the terms of the agreement between FairCom and TDS.
  17. Termination for Material Breach. TDS or Client may terminate the Agreement in its entirety upon written notice to the other in the event that the other party is in default of the performance of any material obligation imposed under this Agreement and the default has not been substantially cured to the satisfaction of the non-defaulting party within thirty (30) days following receipt by the defaulting party of written notice of default (each, an “Event of Default”). An Event of Default specifically includes, but it not limited to, a breach of Client’s obligations to pay for the Software or Services.

  18. Termination for Insolvency. Either Party may terminate the Agreement without notice if the other Party becomes insolvent, makes or has made an assignment for the benefit of creditors, is the subject of proceedings in voluntary or involuntary bankruptcy instituted on behalf of or against such Party, or has a receiver or trustee appointed for substantially all of its property.

  19. Effect of Termination. The termination of this Agreement, whether for breach or otherwise, shall be without prejudice to any claims for damages or other rights against the other party that preceded termination. Any provision of this Agreement which can reasonably be construed to survive the expiration or termination of this Agreement shall survive such expiration or termination and shall not relieve either party of its obligations to observe, keep and perform those surviving provisions.

  20. Client Data (Post-Termination). In the event the License and/or this Agreement is terminated or any reason, TDS shall provide Client with electronic access to all prescription drug order files, including refill information and patient medication records.

  21. Product Functionality. TDS warrants that the Software possesses the functional capabilities described in the documentation for such Software and shall operate in accordance with such documentation in all material respects.

  22. Non-Infringement. TDS warrants that the Software, including Client’s use of the Software, shall not unlawfully infringe upon the copyright, patent or other proprietary rights of others.

  23. No Viruses. TDS warrants that, to the best of TDS’s knowledge, the Software does not contain any viruses, key locks, back doors, trap doors, worms, trojan horses, timers or other disabling devices (collectively, “Non-Beneficial Code”). TDS further warrants that TDS and TDS personnel shall not insert any, or allow any other party to insert any, Non-Beneficial Code into the Software.

  24. Compliance with Applicable Laws. TDS warrants that it shall perform its obligations under this Agreement in a manner that complies with all applicable federal and state laws, rules, regulations and standards (collectively, “Applicable Laws”).

  25. Third-Party Content. TDS does not provide any warranty with respect to any third-party content included within the Software, including, without limitation, content related to drug utilization or other clinical content (the “Clinical Content”). The Clinical Content should not be considered complete and should not be used in place of consultation or advice from a physician, pharmacist, or other healthcare professionals. The Clinical Content is intended to supplement the knowledge of physicians, pharmacists, and other healthcare professionals regarding drug therapy problems and patient counseling information. This information is advisory only and is not intended to replace sound clinical judgment in the delivery of healthcare services. Further, the pricing information contained in the Software is merely an aid to Client regarding comparable pricing in the marketplace, and no warranty is made as to its completeness or accuracy, which could be further degraded in the event Client fails to ensure regular software updates via the Internet.



  28. Binding Agreement. The parties hereto warrant and represent that upon execution hereof, the Agreement shall be a legal, valid and binding obligation on them and shall be enforceable against them in accordance with its terms. The Individuals signing the Agreement warrant and represent that they are duly authorized to sign the Agreement on behalf of the parties hereto.

  29. Waiver. The failure to comply with or to enforce any term, provision, or condition of the Agreement, whether by conduct or otherwise, shall not constitute or be deemed a waiver of any other provision hereof; nor shall such failure to comply with or to enforce any term, provision, or condition hereof constitute or be deemed a continuing waiver. No waiver shall be binding unless executed in writing by the party making the waiver.

  30. Amendments. TDS may amend these Terms and Conditions from time to time and Client agrees to be bound by such amended terms, even if made after the Effective Date of the Agreement. A copy of such amended Terms and Conditions shall be made available to Client at

  31. Notices. All notice, consents, waivers or other communications required or permitted to be given under the terms of the Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) one (1) business day after deposit with a reputable overnight courier service; or (iii) three (3) business days after the mailing of the notice by United States Postal Service certified or registered mail, return receipt requested, in each case properly addressed to the party to receive the same. The addresses for such communications shall be to the respective addresses of the parties as set forth in the Agreement, or at such other address as such parties shall have furnished in writing pursuant to this section.

  32. Severability. Should any part, term, or provision of the Agreement be declared to be invalid, void, or unenforceable, all remaining parts, terms, and provisions hereof shall remain in full force and effect, and shall in no way be invalidated, impaired, or affected thereby.

  33. Assignment. Neither party may assign this Agreement without the prior written consent of the other party; provided, however, that either party may assign this Agreement to: (i) a parent, subsidiary or affiliate who agrees to be bound by the terms of this Agreement; and (ii) a successor-in-interest in the event of a merger (by operation of law or otherwise) or a sale of all or substantially all of a party’s assets.

  34. Applicable Law and Venue. This Agreement shall be governed by the laws of the State of Florida without regard to its conflict of laws provisions and the venue of any litigation arising from this Agreement shall be in the District Courts of Orange County, Florida. The venue of any dispute resolution activity shall be in Orlando, Orange County, Florida.

  35. Subject Headings. The subject headings of the sections, paragraphs, and subparagraphs of this Agreement are included herein solely for the purposes of convenience and reference, and shall not be deemed to explain, modify, limit, amplify, or aid in the meaning, construction, or interpretation of any of the provisions of this Agreement.

  36. Attorney's Fees and Court Costs. If either party brings an action against the other to enforce any condition or covenant of this Agreement, each party shall be individually responsible for its own court costs and attorney's fees.

  37. Relationship of the Parties. None of the provisions of this Agreement are intended to create, and none shall be deemed or construed to create, any relationship between the parties, other than that of independent contractors. This Agreement shall not create the relationship of employer-employee, agency, partnership, or joint venture. Neither party shall have the right or power in any manner to unilaterally obligate the other to any third party, whether or not related to the purpose of this Agreement.
  38. Entire Agreement. This Agreement contains the entire agreement between the parties relating to the rights herein granted and the obligations herein assumed, and supersedes all prior written or oral agreements or communications between the parties.

  39. Force Majeure. Neither party shall be liable or deemed to be in default for any delay or failure in performance under this Agreement or interruption of service resulting, directly or indirectly, from acts of God, civil or military authority, labor disputes, shortages of suitable parts, or any similar cause beyond the reasonable control of the parties (each, a “Force Majeure Event”). Notwithstanding the foregoing, in the event a Force Majeure Event continues for more than thirty (30) days, the party not experiencing the Force Majeure Event shall have the right to terminate this Agreement.



Interested in learning why TDS is the leader in pharmacy solutions?

Our team is dedicated to the community pharmacy industry. Let us show you the difference a true partner can make.